Severity: Critical Alert

Exit/Entry: Authorities in Chad extend 2300-0500 curfew until Sept. 28. International flights at N'Djamena International Airport resumed Aug. 1.

Alert Begins 15 Sep 2020 10:57 AM UTC
Alert Expires 29 Sep 2020 11:59 PM UTC

  • Incident: COVID-19 restrictions
  • Location(s): Nationwide (map)
  • Time Frame: Indefinite
  • Impact: Travel and business disruptions; heightened security

Authorities in Chad have revised and extended the existing 2300-0500 nightly curfew in certain regions through at least Sept. 28 as part of government efforts to slow the spread of coronavirus disease (COVID-19). The curfew is in effect in N'Djamena, Logone Occidental, Logone Oriental, Mayo-Kebbi Ouest, Guera, Kanem, and Mayo-Kebbi Est regions; Mandelia and Lougoun sub-prefectures in Chari-Baguirmi Region; and N'Djamena Fara sub-prefecture in Hadjer-Lamis Region.

During curfew hours, people outside their homes may be subject to questioning and arrest by police or military personnel. Only those participating in the provision of critical services may leave their homes during curfew hours.

Other restrictions and measures remain nationwide, including a ban on travel into and out of the capital, N'Djamena, and all regional capitals. Freight and cargo transport serving these cities is limited. Land borders remain closed to passenger traffic.

Authorities allowed the resumption of limited commercial flights at N'Djamena International Airport (NDJ) to a limited pre-approved list of destinations from Aug. 1. Specific destinations will be announced, depending on the reciprocal opening of airspace with other nations. Travelers to Chad must provide proof of having tested negative for COVID-19 using a test taken within 72 hours prior to departure. Travelers arriving in Chad will be subject to a mandatory seven-day quarantine period. Destinations may be added or removed depending on the evolution of the COVID-19 pandemic. Cargo and emergency flights are ongoing.

Most businesses have resumed operations, though businesses need to adhere to social distancing and sanitation guidelines. Public transport services have also resumed, with limits on the number of passengers allowed in vehicles.

Failure to comply with edicts will result in disciplinary action, including fines and possible incarceration. Authorities could impose additional restrictions based on disease activity in the coming days and weeks.

Background and Analysis
COVID-19 is a viral respiratory disease caused by infection with the SARS-CoV-2 virus (previously known as 2019-nCoV). Symptoms occur 1-14 days following exposure (average of 3-7 days). These symptoms include fever, fatigue, cough, difficulty breathing, sometimes worsening to pneumonia and kidney failure, especially in those with underlying medical conditions. On March 11, the WHO declared the ongoing COVID-19 outbreak a pandemic.

Follow all official instructions. Abide by national health and safety measures. Reconfirm all travel arrangements. Consider delaying traveling if experiencing symptoms associated with COVID-19, as they may prompt increased scrutiny and delays. Liaise with trusted contacts for further updates and guidance. Maintain contact with your diplomatic representation. Ensure contingency plans account for further disruptive measures or extensions of current restrictions. Reconsider and reconfirm nonemergency health appointments. Plan for queues and delays at available shopping centers. Plan for possible ground shipping and travel delays; seek alternative routes and shipping methods for time-sensitive cargo.

Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.

Back to the COVID-19 Risk Intelligence & Resource Center